These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 12835212)

  • 41. Incidence of ventricular tachyarrhythmias during permanent pacemaker therapy in low-risk patients results from the German multicentre EVENTS study.
    Faber TS; Gradinger R; Treusch S; Morkel C; Brachmann J; Bode C; Zehender M;
    Eur Heart J; 2007 Sep; 28(18):2238-42. PubMed ID: 17636308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of atrioventricular node ablation and pacing therapy on clinical course in patients with permanent atrial fibrillation and unstable ventricular tachycardia induced by rapid ventricular response: follow-up study.
    Petrac D; Radićc B; Radeljić V; Hamel D; Filipović J
    Croat Med J; 2005 Dec; 46(6):929-35. PubMed ID: 16342346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack.
    Steinberg JS; Arshad A; Kowalski M; Kukar A; Suma V; Vloka M; Ehlert F; Herweg B; Donnelly J; Philip J; Reed G; Rozanski A
    J Am Coll Cardiol; 2004 Sep; 44(6):1261-4. PubMed ID: 15364329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inappropriate shock despite successful termination of supraventricular tachycardia by antitachycardia pacing during charging.
    Bernier M; Essebag V
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e81-3. PubMed ID: 20230474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
    Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
    Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker.
    Ichiki H; Oketani N; Hamasaki S; Ishida S; Kataoka T; Ogawa M; Saihara K; Okui H; Fukudome T; Shinasato T; Kubozono T; Ninomiya Y; Matsushita T; Otsuji Y; Tei C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):985-90. PubMed ID: 16981923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: efficacy and safety of antitachycardia pacing. A prospective and randomized study.
    Jiménez-Candil J; Arenal A; García-Alberola A; Ortiz M; del Castillo S; Fernández-Portales J; Sánchez-Muñoz J; Martínez-Sánchez J; González-Torrecilla E; Atienza F; Puchol A; Almendral J
    J Am Coll Cardiol; 2005 Feb; 45(3):460-1. PubMed ID: 15680729
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cardiac pacemakers and implantable cardioverter-defibrillators in the perioperative phase].
    Kemnitz J; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Jun; 28(4):199-212. PubMed ID: 8353196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access.
    Jaroszewski DE; Altemose GT; Scott LR; Srivasthan K; Devaleria PA; Lackey J; Arabia FA
    Ann Thorac Surg; 2009 Jul; 88(1):112-6. PubMed ID: 19559206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.
    Boriani G; Gasparini M; Lunati M; Santini M; Landolina M; Vincenti A; Curnis A; Bocchiardo M; Padeletti L; Biffi M; Allaria L; Denaro A;
    Am Heart J; 2006 Sep; 152(3):527.e1-11. PubMed ID: 16923425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator.
    Daoud EG; Nademanee K; Fuenzalida C; Tomassoni GF; Schuger C; Chisner M; Simones M; Schwartz M; Reeve H
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):852-6. PubMed ID: 16903964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implantation of dual chamber pacemaker defibrillator and placement of endocardial leads via the axillary vein.
    Yang J; Powell A; Davis M
    Chin Med J (Engl); 2001 Jun; 114(6):568-70. PubMed ID: 11780428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Device management of arrhythmias after Fontan conversion.
    Tsao S; Deal BJ; Backer CL; Ward K; Franklin WH; Mavroudis C
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):937-40. PubMed ID: 19660377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design.
    Quesada A; Botto G; Erdogan A; Kozak M; Lercher P; Nielsen JC; Piot O; Ricci R; Weiss C; Becker D; Wetzels G; De Roy L;
    Europace; 2008 Mar; 10(3):321-6. PubMed ID: 18308753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.